Cite
HARVARD Citation
Hall, M. et al. (n.d.). 984PClinical outcomes according to age and comorbidities in the OSCAR UK observational study of front-line bevacizumab (BEV)-containing therapy for advanced ovarian cancer (aOC). Annals of oncology. p. . [Online].